CLINICAL_TRIALS
trial_result
· 2016-05-30
Clinical Trial Update: Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204) [Phase 3]
Summary
A Phase 3 trial update reports efficacy and safety results for desloratadine (MK-4117) in Japanese participants with Seasonal Allergic Rhinitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Organon and Co | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2016-05-30